Cibc World Markets Corp acquired a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 8,030 shares of the company's stock, valued at approximately $770,000.
Several other institutional investors have also recently modified their holdings of HQY. Arcadia Investment Management Corp MI purchased a new position in HealthEquity in the 4th quarter worth $26,000. Smartleaf Asset Management LLC grew its stake in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity in the fourth quarter worth about $39,000. UMB Bank n.a. increased its holdings in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ lifted its stake in shares of HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after acquiring an additional 445 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts have commented on the company. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their price target for the stock from $120.00 to $115.00 in a research note on Tuesday. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. Barrington Research reaffirmed an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a research note on Friday, March 14th. KeyCorp cut their price target on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Monday. Finally, JMP Securities upped their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, HealthEquity has an average rating of "Buy" and an average price target of $113.31.
Read Our Latest Stock Analysis on HQY
HealthEquity Stock Down 0.1 %
Shares of HQY traded down $0.13 during mid-day trading on Tuesday, reaching $90.19. The company had a trading volume of 2,054,483 shares, compared to its average volume of 698,236. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market capitalization of $7.80 billion, a price-to-earnings ratio of 82.74, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The firm has a 50-day moving average price of $104.40 and a 200 day moving average price of $95.94. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59.
Insider Buying and Selling at HealthEquity
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.20% of the stock is owned by company insiders.
HealthEquity Company Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.